{{Rsnum
|rsid=1429409
|Chromosome=2
|position=16227278
|Orientation=minus
|GMAF=0.1226
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 3.2 | 96.8
| HCB | 6.8 | 65.9 | 27.3
| JPT | 7.0 | 51.2 | 41.9
| YRI | 0.0 | 5.0 | 95.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.8 | 65.9 | 27.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23920401
|Title=Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients
}}

{{on chip | HumanOmni1Quad}}